Biotech

All Articles

Turnstone lays off 60%, shocks C-suite to stretch out money

.Turnstone Biologics is lowering its head count by 60% and also shaking up its own C-suite so as to ...

Gilead gives up on $15M MASH wager after mulling preclinical data

.In a year that has viewed a confirmation as well as a raft of readouts for metabolic dysfunction-as...

Texas biotech axes cancer cells pact, pins wishes on weight problems

.Alaunos Therapies is actually axing a deal along with Precigen, giving up licensing rights to a per...

Capricor allotments extra information for DMD treatment after triggering BLA

.Capricor Rehabs is taking a victory tour for their stage 2 Duchenne muscular dystrophy (DMD) test. ...

FDA locations Kezar lupus test in hold adhering to 4 individual deaths

.The FDA has actually placed Kezar Lifestyle Sciences' lupus test on grip after the biotech flagged ...

Phase 3 Scholar Stone test hits SMA goal, sending out stockpile 200%

.A period 3 test of Intellectual Stone's vertebral muscular atrophy (SMA) prospect has actually stru...

CAMP 4 is actually most up-to-date to eye IPO, while Upstream point out $182M plan

.RNA biotech CAMP4 Rehabs has actually defined plans for a $67 thousand IPO, along with inflammation...

Galecto acquires leukemia medicine, loses bone tissue cancer possession in pivot

.A year after the failing of an idiopathic lung fibrosis prospect delivered Galecto on a search for ...

Judo tosses down $100M to knock out kidney disease

.Taking the mat is Judo Biography, a promising biotech armed along with $100 million to develop olig...

AstraZeneca spends CSPC $100M for preclinical heart problem medication

.AstraZeneca has paid off CSPC Pharmaceutical Team $one hundred million for a preclinical heart dise...